Ultrasound Contrast Agents Need New Safety Trial After Discouraging Advisory Cmte.
Executive Summary
An FDA advisory panel member suggests having a third party design future safety studies for ultrasound contrast agents.
You may also be interested in...
Ultrasound Contrast Agents Should Drop Boxed Warning, Medical Society Tells FDA
Citizen petition by the International Contrast Ultrasound Society says updated safety data from recent meta-analysis makes black box unnecessary.
FDA Reestablishes Imaging Drugs Committee, Citing Application Surge
The increasing number of new medical imaging drugs FDA is asked to review has led the agency to reestablish an advisory committee devoted exclusively to them.
FDA Reestablishes Imaging Drugs Committee, Citing Application Surge
The increasing number of new medical imaging drugs FDA is asked to review has led the agency to reestablish an advisory committee devoted exclusively to them.